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Egg Yolk Antibodies and Nanotechnology Applied 
 to Animal Health and Production
Introduction
Nanotechnology is a rapidly developing area of science and 
technology, which deals with the application, production and 
processing of materials with sizes less than 100nm (a nanometer 
being one billionth of a meter). In addition, it is an interdisciplinary 
science comprising of various disciplines such as physics, chemistry, 
electronics, material science, health science, biology, and veterinary 
science, and it has impact on many industries [1]. 
The ability to manufacture and manipulate material at 
nanoscale has offered opportunities to interface biological systems 
with outer world in new ways and with unprecedented precision. 
These emerging technologies have indicated great potential 
in functional foods and nutraceuticals for delivering bioactive 
compounds in functional foods to improve human and animal 
health [2,3]. Nanoscience and engineering can offer significant 
improvements in food safety, packaging and ultimately, novel food 
ingredients, because nanotechnology may create different and new 
properties [4]. Applications of nanotechnology in the food industry 
have been developing more slowly than other areas because of their 
complex structures and sensitivity. Some applications in the food 
industry are improving the uptake, absorption, and bioavailability 
of nutrients and supplements in the body, producing new or 
improved tastes, and textures of foods, improving food-packaging 
materials, developing nanosensors that can give information about 
the freshness or spoilage of products during transportation, storage 
of food products [5].
In this section, general particularities and applications 
of nanotechnology will be discussed with a special focus in 
nanocomposites for oral administration of IgY.
Nanomedicine for Therapeutics and Drug Delivery of 
IgY 
Avian IgY antibodies have many attractive advantages over 
IgG in biochemical, immunological and production applications. 
 
Recent advances in the use of IgY and nanomedicine shows 
good properties in diagnostic applications. Egg yolk antibodies 
have been absorbed onto gold nanoparticles to make nano gold-
IgY conjugates with possible uses in membrane isolation and 
nanotherapeutics [6]. Also, in immunehistochemistry, Xiao & Gao 
[7] have shown that combining the high sensitivity and specificity 
of IgY and the high brightness and photo stability of quantum dots 
can improve detection and quantitation of biomarkers. In another 
study, homogeneous immunoassay for human IgG using oriented 
hen egg IgY immobilized on gold sol nanoparticles has been 
presented with a wide detection range and a limit of detection of 
30ng.mL-1 of human IgG [8].
In animal production, the oral administration of IgY as 
prophylaxis or passive immmunization requires considerations 
about its stability to gastric pH, proteolytic degradation and heat 
stability due to technological processes that are involved in the 
industrial processing of IgY. Therefore, to use the IgY as passive 
immunotherapy, it is necessary to find an effective method for 
preserver the biological function and therapeutic efficacy of this 
antibody during gastric passage. 
Various techniques of micro and nano-encapsulation have been 
developed to protect IgY of the gastric inactivation. Shimizu et al. [9] 
reported that liposomal membrane prepared from egg yolk lecithin 
was almost completely stable against digestion by pepsin. The 
encapsulation of IgY, using enteric-coated gelatin capsules, has also 
been examined, and was found to significantly improve antibody 
stability [10]. An in vivo study using pigs as a model digestion, a 
coating of IgY-containing granules with a pH-sensitive methacrylic 
acid copolymer was found to protect IgY from gastric inactivation 
[11]. Cho et al. [12] showed that two different emulsification 
methods involving multiple emulsification and heat gelation were 
for preparation of whey protein-based microcapsules containing 
immunoglobulin in yolk (IgY) were effective in protecting IgY 
from highly acidic conditions and heat treatment processes. The 
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enhanced stability of IgY under harsh conditions and IgY storage 
stability were useful for applications in the food processing industry.
Other report described the use of microencapsulated and 
liposomes to protect IgY degradation. Microencapsulation with 
10% or 20% b-cyclodextrin (b-CD) and arabic gum by a spray-drier 
was effective in protecting the IgY activity against pepsin. Liposome 
prepared at the lecithin/cholesterol ratio of 1/0.25 (mole/mole) 
displayed satisfactory encapsulation efficiency (69%) of IgY. 
Increase in cholesterol content in the liposomal structure exhibited 
a stronger protection effect of IgY against pepsin and acid [13]. On 
the other hand, Torché et al. [14] used PLGA-MS (poly (D, L-lactide-
co-glycolide)microspheres) to administrated locally (surgical 
technique), into the duodenum, an immunogenic protein (IgY) to 
evaluate systemic immune response in SPF Large White pigs. They 
proposed PLGA MS as a potential oral delivery system for antigen. 
Otherwise, Li et al. [15,16] reported the use of chitosan-alginate 
microcapsules to protect IgY anti- K88+ ETEC (enterotoxigenic 
E. coli)-induced diarrhea using an in vivo pig model. Chitosan-
alginate microspheres could effectively protect the IgY antibodies 
from gastric inactivation after oral administration, resulting in an 
enhanced protection against ETEC-induced diarrhea in older pigs. 
Since the protein- and peptide-based drugs were highly susceptible 
to the gastrointestinal environments, some efforts were put on this 
area. Also, sucralfate, and anti-peptide ulcer agent, was evaluated 
to protect IgY (anti-H. pylori VacA) by oral preparations which 
can tolerate acid and pepsin. Over 30% sucralfate enhanced the 
tolerance of IgY to low pH value and pepsin and the anti-freeze 
thawing ability [17].
In vitro study of IgY protection by nanocomposites and 
toxicity evaluation 
The rational design of nutraceuticals delivered by micro/
nanocomposites requires the understanding of the relationship 
between the structure of the protein and their functional properties. 
Also it is necessary to understand the impact of the encapsulation 
system on the stability and the controlled liberation of the protein 
of interest on the targeted site.
As shown previously, a wide variety of micro/nanocomposites 
based delivery system has been described for the encapsulation of 
IgY. Recently, a new approach for the protection of IgY in simulated 
gastric conditions has been described. First, an anti-Escherichia 
coli IgY was obtained and characterized [18]. Then, intelligent 
hydrogels with ph-sensitive properties were synthesized and used 
to encapsulate the anti-Escherichia coli IgY. 
The capacity of these structures to load, protect and release 
this IgY and the interaction between the IgY and hydrogels by 
Fourier Transform Infrared (FT-IR) spectroscopy were evaluated. 
The particle size and swelling percentage of the hydrogels were 
highly dependent on the pH of the buffer solution and the hydrogels 
could efficiently incorporate IgY and protect the IgY from simulated 
gastric conditions. However, IgY was slowly released at basic pH 
and a high percentage remained inside. The IR spectra showed 
that IgY interacts with the hydrogel in its network with extended 
hydrogen bonds [19]. 
The intelligent hydrogels were then improved and composite 
materials based on hydrogels and Carbon NanoTubes (CNT) were 
generated. For the synthesis, first oxidized CNT were wrapped with 
Chitosan (CH) and analyzed by FT-IR. Studies with Transmission 
Electron Microscopy (TEM) could confirm a CH layer lying around 
CNT. Chitosan wrapped CNT were then incorporated to the 
intelligent hydrogels for generate nanocomposites for protection 
and delivery of IgY. Swelling behavior in buffers at different pH 
revealed a significantly lower swelling when nanocomposites were 
exposed to an acid buffer solution. The mechanical properties of 
this delivery system were evaluated by measurements of elasticity 
and the hydrogels containing CNT-CH showed more resistance. 
The incorporation and liberation of IgY from hydrogel-CNT-CH 
were also assessed revealing an improved performance compared 
with the pure hydrogel. Hydrogel nanocomposites have been used 
in numerous biomedical applications and remote controlled drug 
delivery systems. However, only few studies have been reported so 
far on the biocompatibility of hydrogel-CNT-CH nanocomposites. 
The evaluation of the effect of these nanocomposites on cellular 
red ox balance of intestinal cells shows that the composites 
induce no oxidative stress. Cytotoxicity and apoptosis were 
also evaluated and there were no evidence of cytotoxicity or cell 
death. These preliminary findings are suggesting that hydrogel-
CNT-CH nanocomposites show improved properties and good 
biocompatibility in vitro making these biomaterials promising 
systems for IgY delivery purposes [20].
Nanotechnology for Bovine Production Applications 
The use of the nanotechnology to veterinary medicine 
provides the opportunity for improving drug, molecules, and 
vaccine delivery and for bulk application to extensive production 
systems. However, there are still very limited the in vivo studies 
of nanotechnology applied to animals. Little investigations have 
been evaluated the application of nanoparticle-based therapeutics 
in bovines, among which may be mentioned: liposome for 
intramammary administration of streptomycin and gentamicin, 
liposome for intravenous application of adriamycin, niosome for 
intravenous application of flurbiprofen, liposome for transdermal 
administration of diclofenac [21]. 
Passive immunization using specific IgY antibodies has been 
previously studied in bovine, and its application has been carried 
to different objectives: protection against E. coli K99+ infection, 
reduction of E. coli O157:H7 fecal shedding in feedlot steer, growth 
inhibition, internalization, and uptake by macrophages of E. coli 
O111. Protection against Bovine Rotavirus-induced diarrhea 
in neonatal calves, reduction of morbidity and mortality due to 
respiratory pathogens in calves also has been described. Finally, 
the reduction of ruminal counts of Fusobacterium necrophorum 
and Streptococcus bovis, and reduction of symptoms in clinical 
and experimental mastitis caused by Staphylococcus aureus was 
reported [22]. 
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Previous IgY encapsulation methods has been shown a marked 
effect on the protection of this antibody from degradation under 
physiological digestive conditions, allowing its oral administration. 
Recently, it has been investigated the oral administration of IgY 
into previously described hydrogel-CNT-CH composites for the 
prevention of calf neonatal diarrhea caused by ETEC [18]. These 
delivery systems enhanced the efficiency of incorporation of IgY, 
allowed its controlled-time release and protected it of gastric 
inactivation. The administration of anti-ETEC IgY encapsulated 
into these nanocomposites, decreased the number of animals 
affected, the severity and duration of diarrhea. Necroses, atrophy 
of villous and inflammatory reactions were not observed in the 
intestinal mucosa of calves evaluated after administration of 
the nanocomposites. Significant differences in the percentage 
of degranulated and non-degranulated mast cells were not 
observed in any of the studied calves. Therefore, hydrogel-CNT-
CH nanocomposites could be used as an effective vehicle for oral 
administration of IgY in passive therapies.
Nanotechnology for Porcine Production Applications 
Porcine production is in increasing growing and new 
technologies application. As principal problems derived from 
overcrowding there may be mentioned stress and health diseases. 
Swine neonatal diarrhea is one of the major causes of death and 
economic losses in swine production and the main etiological agent 
is Entero Toxigenic Escherichia coli (ETEC) around of world [23,24]. 
These problems have led producers to carry out breeding practices 
under strictly controlled sanitary conditions. However, not all 
these practices are enough to achieve ideal sanitary conditions, 
mainly due to the environmental survival capacity of E. coli strains. 
Moreover, extended use of antibiotic generates a considerable 
amount o resistance [25]. As an alternative of antibiotics emerged 
the egg yolk immunoglobulin (IgY). Oral administration of IgY, as 
a passive immunization strategy, present a promising approach 
for human and animals [26]. The successful use of IgY in pigs was 
reported previously by Kovacs-Nolan & Mine [22].
The use of the nanotechnology applied to porcine delivery of 
different drugs has been reported. Little investigations have been 
evaluated the application of nanoparticle-based therapeutics in 
porcine, among which may be mentioned: dendrimers as vaccine 
adjuvants to prevent foot and mouth disease, liposome to delivery 
of vitamin E and polymeric particles to delivery of E. coli fimbriae 
as vaccine [21]. 
Recently, it has been investigated the oral administration of IgY 
into hydrogel-CNT-CH nanocomposites as a promising strategy of 
IgY delivery on intestinal tract. It was found that protected IgY was 
effective for the prevention of neonatal porcine diarrhea caused 
by ETEC. Neither symptoms nor signs of diarrhea disease were 
observed on piglets challenged and treated with IgY administered 
by hydrogel-CNT-CH nanocomposites, compared with challenged 
not-treated and challenges-treated with free IgY animals [23]. 
Nanotechnology shows to improve the efficiency of IgY to prevent 
piglet diarrhea, without toxic effects. 
Concluding Remarks and Future Trends 
Diarrhea in young animals is one of the most important diseases 
that affect livestock industry and continuing to cause high economic 
losses worldwide due to increased mortality, medication costs and 
decreased weight gain. A recent analysis has demonstrated the 
beneficial effect of IgY in controlling and preventing the diarrhea in 
domesticated animals. This supports the opinion that IgY is useful 
for prophylaxis and treatment of gastrointestinal infection by oral 
passive immunization as an alternative strategy to antibiotics. 
Hydrogel-CNT-CH nanocomposites show efficiently incorporate the 
anti-E. coli IgY. Despite the incomplete release of the therapeutic 
agent, protected IgY could improve the health status of E. coli 
challenged piglets and calves. Due the similarity between pigs 
and humans in terms of anatomy, genetics, and physiology the 
results obtained with hydrogel-CNT-CH nanocomposites can help 
to solve an important disease in Argentine and worldwide such us 
hemolytic-uremic syndrome. Additional studies will be necessary 
to improve several aspects like liberation rate and scalability.
The conjunction of IgY technology and nanotechnology has the 
capacity to offer innovative biosensors to applied in human and 
veterinary medicine. Recently, several articles have been published 
using IgY for immune diagnostic since it high sensitivity, specificity 
showing very interesting IgY capturing capabilities.
Although there are gaps that need to be filled, veterinary 
nanotechnology holds a great key in diagnostics and therapeutics 
of animal diseases and research is being intensified to breach the 
gaps.
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